News

Vectura will license dry powder formulation technology to GlaxoSmithKline for use in respiratory products for up to £20 million. The deal is for worldwide rights and is non-exclusive. Read the company's press release. … [Read more...] about GSK licenses DPI formulation technology from Vectura